Enveric Biosciences Inc (ENVB) Stock Price, Quote & News

Company Profile

Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. The company offers product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health. It also focuses on the development of cannabinoid conjugate molecules...

Industry: Biotechnology

Sector: Healthcare

Website: www.enveric.com

Address:

245 First Street, Riverview II 18 th Floor, Cambridge, United States

Luckyjs38 Dec. 4 at 4:57 PM

$ORBS $GREE $ENVB $FLGC $CEIN

0 · Reply

Luckyjs38 Dec. 4 at 4:34 PM

$ORBS In my opinion based on extensive DD and TA , Today’s extremely undervalued Runners are $GREE $ENVB $FLGC $CEIN $ORBS see you🎁🐦‍🔥

0 · Reply

SeabeeDon Dec. 4 at 4:27 PM

$ENVB I've been quiet, but still here. Waiting on patent settlement agreement. Hopefully we see a nice run up in anticipation of it. Depending on how the agreement plays out, stock could easily 5x from these levels.

0 · Reply

Luckyjs38 Dec. 4 at 3:11 PM

$ENVB We got a Runner 🐦‍🔥

0 · Reply

Luckyjs38 Dec. 3 at 8:02 PM

$ENVB HODL

0 · Reply

RBLUCKY Dec. 2 at 5:21 PM

$ENVB even if they did what kind of settlement would they give a tiny microscopic company like Enveric, the market cap is 3.4 million. If anything they would just buy the company for 5 million and dissolve it. It’s a public company so there’s no way you’re gonna get hope on big settlement.

0 · Reply

Luckyjs38 Dec. 2 at 4:12 PM

$IWM $GREE $ORBS $ENVB $SPY

0 · Reply

Luckyjs38 Dec. 2 at 4:01 PM

$ENVB Ill keep loading every week this will 200X when settlement hits and EB-003 clears phase 1 human trial's with positive results early 2026 🇺🇸❤️

0 · Reply

Luckyjs38 Dec. 2 at 3:55 PM

$IWM Buckle up Break out Primed and Loaded $GREE $ORBS $ENVB $SPY 🐦‍🔥 Load the Boat 🚤

0 · Reply

Luckyjs38 Dec. 1 at 5:34 PM

$ENVB 10k share goal here accumulating

1 · Reply

Enveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 9th Annual Neuroscience Innovation Forum During “J.P. Morgan Week 2026”

Nov 26, 2025, 8:00 AM EST - 9 days ago

Enveric Biosciences Receives Fourth Notice of Allowance for EVM401 Series of Drug Candidates

Nov 14, 2025, 4:05 PM EST - 20 days ago

Enveric Biosciences Reports Third Quarter 2025 Financial and Corporate Results

Oct 23, 2025, 8:00 AM EDT - 6 weeks ago

Enveric Biosciences Announces Reverse Stock Split

Oct 16, 2025, 8:30 AM EDT - 7 weeks ago

Enveric Biosciences Further Enhances Intellectual Property Estate with New U.S. Patent Issuance

Oct 15, 2025, 8:00 AM EDT - 7 weeks ago

Enveric Biosciences Hires IP Powerhouse to Defend Its U.S. Patent with Claims Relevant to Bretisilocin, Recently Acquired by AbbVie in $1.2 Billion Deal

Oct 14, 2025, 9:00 AM EDT - 7 weeks ago

Enveric Biosciences to Explore Digital Asset Treasury Opportunities

Oct 2, 2025, 8:45 AM EDT - 2 months ago

Enveric Biosciences Successfully Completes Key Manufacturing Milestones in Support of Planned IND and Clinical Trials

Sep 18, 2025, 4:30 PM EDT - 2 months ago

Enveric Biosciences Announces Closing of Exercise of Warrants for $2.2 Million Gross Proceeds

Sep 17, 2025, 9:24 AM EDT - 2 months ago

Enveric Biosciences Announces Exercise of Warrants for $2.2 Million Gross Proceeds

Sep 17, 2025, 8:00 AM EDT - 2 months ago

Enveric Biosciences Announces Publication of Two Peer-Reviewed Articles Highlighting Novel Bioproduction Methods for Neuropsychiatric Drug Discovery

Sep 16, 2025, 8:45 AM EDT - 2 months ago

Enveric Biosciences Receives FDA Response and Streamlines Plans for EB-003 IND Submission

Sep 3, 2025, 8:30 AM EDT - 3 months ago

Enveric Biosciences to Present at H.C. Wainwright 27th Annual Global Investment Conference

Sep 2, 2025, 8:30 AM EDT - 3 months ago

Enveric Biosciences Relocates Corporate Headquarters to Cambridge, MA

Aug 28, 2025, 8:30 AM EDT - 3 months ago

Enveric Biosciences Successfully Completes Pre-IND Dose Range Finding Studies for Lead Candidate EB-003, Targeting Neuropsychiatric Indications

Aug 14, 2025, 8:00 AM EDT - 4 months ago

Enveric Biosciences Reports Second Quarter 2025 Financial and Corporate Results

Jul 23, 2025, 8:03 AM EDT - 4 months ago

Enveric Biosciences Secures Second U.S. Patent Allowance for Next-Generation, Non-Hallucinogenic Mescaline Derivatives in EVM401 Series

Jul 15, 2025, 9:03 AM EDT - 5 months ago

Enveric Biosciences Lead Drug Candidate EB-003 Demonstrates Positive Effects in Preclinical Model of Post-Traumatic Stress Disorder (PTSD)

Jun 24, 2025, 9:03 AM EDT - 5 months ago

Enveric Biosciences Announces Data that Broadens Scope of Clinical Indication Potential for Lead Candidate EB-003

Jun 16, 2025, 10:46 AM EDT - 6 months ago

Enveric Biosciences Announces Participation in 2025 BIO International Convention

Jun 10, 2025, 9:03 AM EDT - 6 months ago

Enveric Biosciences Receives Notice of Allowance for New Class of Low-Hallucinogenic Neuroplastogens Targeting Psychiatric Disorders

Jun 3, 2025, 9:00 AM EDT - 6 months ago

Enveric Biosciences Announces Issuance of U.S. Patent Covering a Novel Family of Molecules Including Melatonin Receptor-Targeting Compounds

May 28, 2025, 9:03 AM EDT - 6 months ago

Enveric Biosciences Reports Positive Preclinical Results for Lead Drug Candidate EB-003

May 20, 2025, 8:00 AM EDT - 7 months ago

Enveric Biosciences Identifies Neuroplastogen Candidates with Potential to Address Neurodegenerative Disease

May 14, 2025, 4:15 PM EDT - 7 months ago

Enveric Biosciences Reports First Quarter 2025 Financial and Corporate Results

Mar 31, 2025, 8:00 AM EDT - 8 months ago

Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2024

Mar 17, 2025, 1:40 PM EDT - 9 months ago

Enveric Biosciences Participating in BIO-Europe Spring®

Mar 6, 2025, 10:00 AM EST - 9 months ago

Enveric Biosciences Launches Request-For-Proposals Solicitation Process for PsyAI Trademark

Feb 27, 2025, 9:30 AM EST - 10 months ago

Enveric Biosciences CEO Issues Letter to Shareholders

Feb 25, 2025, 1:30 PM EST - 10 months ago

Enveric Biosciences Unveils EVM401 Series of Compounds with New U.S. Patent

Feb 4, 2025, 8:00 AM EST - 10 months ago

Enveric Biosciences and Restoration Biologics Announce Licensing Agreements to Treat Joint Disease

Feb 3, 2025, 5:00 PM EST - 10 months ago

Enveric Biosciences Announces Closing of $5 Million Public Offering

Jan 30, 2025, 8:14 PM EST - 11 months ago

Enveric Biosciences Announces Pricing of $5 Million Public Offering

Jan 30, 2025, 4:01 PM EST - 11 months ago

Enveric Biosciences Receives Notice of Allowance for Lead Drug Candidate EB-003 from United States Patent and Trademark Office

Jan 6, 2025, 8:30 AM EST - 11 months ago

Enveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 8th Annual Neuroscience Innovation Forum During “J.P. Morgan Week 2025”

Dec 2, 2024, 8:00 AM EST - 1 year ago

Enveric Biosciences Announces New U.S. Patents Supporting EVM301 Series and EVM201 Series Compounds

Nov 25, 2024, 9:00 AM EST - 1 year ago

Enveric Biosciences Preclinical Pharmacokinetic Studies of EB-003 Support Oral Bioavailability, Demonstrate Brain Penetration, and Show No Evidence of Hallucination-like Behavior

Nov 14, 2024, 4:05 PM EST - 1 year ago

Enveric Biosciences Reports Third Quarter 2024 Financial and Corporate Results

Nov 12, 2024, 9:00 AM EST - 1 year ago

Enveric Biosciences Signs Out-Licensing Agreement with MycoMedica Life Sciences for EB-002

Nov 4, 2024, 10:36 AM EST - 1 year ago

Enveric Biosciences Announces Broad Range of Patent Issuances

Oct 15, 2024, 8:00 AM EDT - 1 year ago

Enveric Biosciences Announces Positive Pharmacology and Safety Data for Lead Product, EB-003

Sep 26, 2024, 8:30 AM EDT - 1 year ago

Enveric Biosciences Presents Data Highlighting Development of EB-003 at European Behavioral Pharmacology Society Biennial Workshop

Sep 25, 2024, 8:30 AM EDT - 1 year ago

Enveric Biosciences Presents Data on Lead Product Candidate, EB-003, at 7th Neuropsychiatric Drug Summit

Sep 4, 2024, 8:00 AM EDT - 1 year ago

Enveric Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Aug 13, 2024, 8:00 AM EDT - 1 year ago

Aries Science & Technology and Enveric Biosciences Announce Issuance of Key US Patent Under Aries' License for Treatment of Radiation Dermatitis and Other Conditions

Aug 12, 2024, 5:30 PM EDT - 1 year ago

Enveric Biosciences Reports Second Quarter 2024 Financial and Corporate Results

Jul 25, 2024, 8:00 AM EDT - 1 year ago

Enveric Biosciences Announces Preclinical Results Confirming Potential of EB-003 to be Dosed Orally

Jul 15, 2024, 9:02 AM EDT - 1 year ago

Aries Science & Technology and Enveric Biosciences Announce Licensing Agreement

Jul 10, 2024, 8:00 AM EDT - 1 year ago

Enveric Biosciences Announces Patent Granted for Drug Candidate

Jun 28, 2024, 8:00 AM EDT - 1 year ago

Diamond Equity Research Releases Update Note on Enveric Biosciences Inc. (NASDAQ: ENVB)

MBIO

Luckyjs38 Dec. 4 at 4:57 PM

$ORBS $GREE $ENVB $FLGC $CEIN

0 · Reply

Luckyjs38 Dec. 4 at 4:34 PM

$ORBS In my opinion based on extensive DD and TA , Today’s extremely undervalued Runners are $GREE $ENVB $FLGC $CEIN $ORBS see you🎁🐦‍🔥

0 · Reply

SeabeeDon Dec. 4 at 4:27 PM

0 · Reply

Luckyjs38 Dec. 4 at 3:11 PM

$ENVB We got a Runner 🐦‍🔥

0 · Reply

Luckyjs38 Dec. 3 at 8:02 PM

$ENVB HODL

0 · Reply

RBLUCKY Dec. 2 at 5:21 PM

0 · Reply

Luckyjs38 Dec. 2 at 4:12 PM

$IWM $GREE $ORBS $ENVB $SPY

0 · Reply

Luckyjs38 Dec. 2 at 4:01 PM

$ENVB Ill keep loading every week this will 200X when settlement hits and EB-003 clears phase 1 human trial's with positive results early 2026 🇺🇸❤️

0 · Reply

Luckyjs38 Dec. 2 at 3:55 PM

$IWM Buckle up Break out Primed and Loaded $GREE $ORBS $ENVB $SPY 🐦‍🔥 Load the Boat 🚤

0 · Reply

Luckyjs38 Dec. 1 at 5:34 PM

$ENVB 10k share goal here accumulating

1 · Reply

Hopscotch1 Dec. 1 at 4:35 PM

$ENVB hmmmm -

0 · Reply

Luckyjs38 Nov. 26 at 2:52 PM

$GME $AMC $GREE $ENVB

0 · Reply

CoralSharkie Nov. 26 at 2:25 PM

$ENVB Near 52 weeks low with 500k float could run on news/ volume imo. Worth to keep it on watch!!

0 · Reply

Stockships Nov. 26 at 1:53 PM

$ENVB Fresh news just hit for ENVB, and with a float under 700,000 shares, this Go look at November 3rd: ENVB ripped over 50%. Check November 5th: another 40%+ surge. Stockships.com/disclaimer $DVLT $CTXR $AMBR $NVDA

0 · Reply

Luckyjs38 Nov. 26 at 1:01 PM

$GME $AMC $HYMC $GREE $ENVB

0 · Reply

Luckyjs38 Nov. 26 at 4:21 AM

$GME $AMC $HYMC $GREE $ENVB Commence Santa Bull run 🎁🐦‍🔥

0 · Reply

Luckyjs38 Nov. 25 at 5:30 PM

$GME Squeeze $AMC $GREE $ENVB extremely undervalued hidden gems

0 · Reply

Luckyjs38 Nov. 25 at 5:29 PM

$ENVB

0 · Reply

Luckyjs38 Nov. 25 at 4:53 PM

$ENVB $ENVB @Enveric_Bio is utilizing Ai technology to advance modern science and find break through molecules helpful to man kinds health,wellbeing, and longevity ❤️🇺🇸

0 · Reply

Luckyjs38 Nov. 25 at 4:38 PM

$AMC $GME $ENVB

0 · Reply

Luckyjs38 Nov. 25 at 3:02 PM

$AMC $GME $ENVB 🐦‍🔥 Boom

0 · Reply

CoralSharkie Nov. 24 at 11:39 PM

$ENVB could run float is 500k on watch

0 · Reply

Market Cap	3.47M
Revenue (ttm)	0.00
Net Income (ttm)	-9.57M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	52,300
Avg Vol	81,690
Day's Range	N/A - N/A
Shares Out	597,000.00
Stochastic %K	40%
Beta	0.22
Analysts	Strong Buy
Price Target	$10.00